Samuel Jacob Klempner, MD
Associate Professor, Harvard Medical School, Mass General Brigham Cancer Institute / Massachusetts General Hospital
The goal of this activity is for learners to be better able to optimize outcomes for patients with HER2-positive GEA through the practical application of recent data regarding the safety and efficacy of HER2-targeted therapies.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.5 credits
MOC types
ABIM — Medical KnowledgeUp to 0.5 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 283 - 299 Market St.
Pricing
100% of listed courses are free
300 of a sample of 300 are free · 1,253 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Breast Imaging
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Clinical Informatics
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Facial Plastic & Reconstructive Surgery
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetric Anesthesia
- Obstetrics & Gynecology
- Ophthalmology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Gastroenterology
- Pediatric Neurology
- Plastic & Reconstructive Surgery
- Preventive Medicine
- Primary Care Sports Medicine
- Pulmonary Disease
- Rheumatology
- Rhinology
- Sleep Medicine
- Transplant Hepatology
- Urological Oncology
- Vascular Neurology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Faculty 1
All faculty
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedNov 27, 2025
-
Last day to claim creditNov 28, 2026 7 weeks left
-
Physicians’ Education Resource New Precision Strategies for HER2+ GEA: Interpreting New Data to Inform Clinical Practice
-
touchIME +1 HER2 in focus: Advancing treatment for biliary tract and gastroesophageal cancers
-
PVI, PeerView Institute for Medical Education Precision-Guided Interventions in HER2+ GI Tumors Expert Perspectives on Operationalizing The Latest Evidence on Antibody-Drug Conjugates For Advanced Disease
-
Medscape, LLC Ready for Launch in Gastroesophageal Adenocarcinoma: Anti-HER2 Innovation in First-Line Management
-
Medscape, LLC The APP Role in Advancing Anti-HER2 Treatment for Gastroesophageal Adenocarcinoma
-
Medscape, LLC HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancer: Updates and Insights
